SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-132855
Filing Date
2024-12-03
Accepted
2024-12-03 17:05:11
Documents
12
Period of Report
2024-12-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20241203.htm   iXBRL 8-K 47399
2 EX-3.1 apvo-ex3_1.htm EX-3.1 20031
  Complete submission text file 0000950170-24-132855.txt   193433

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20241203.xsd EX-101.SCH 26999
14 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20241203_htm.xml XML 5106
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 241523600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)